US11464816B2ActiveUtilityA1
Supplement for menopause
Est. expiryApr 16, 2039(~12.8 yrs left)· nominal 20-yr term from priority
A23L 33/105A61K 33/06A61K 31/405A61K 31/4045A61K 45/06A61K 36/81A23V 2002/00A61K 31/198A61P 5/00A61K 9/0053A61K 36/15A61K 31/522
72
PatentIndex Score
0
Cited by
40
References
1
Claims
Abstract
This disclosure relates to a supplement, particularly a supplement for menopause.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of treating menopause in a woman in need thereof consisting essentially of orally administering to the woman in need thereof therapeutically effective amounts of an ashwagandha extract and pine bark extract to effectively treat the menopause in the woman in need thereof wherein the ratio of the ashwagandha extract to the pine bark extract is 5:1 to about 10:1, respectively.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.